Suppressing AAG activity with antisense oligonucleotides (ASO) in MGMT-expressing, MGMT-deficient and MGMT- and mismatch repair-deficient GBM lines increased Me-Lex sensitivity assayed by survival of colony-forming ability (Bobola et al., 2007). The gene discussed is MGMT; the disease is glioblastoma.